News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Talha Badar/X
Mar 4, 2025, 10:55

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Jing Lu, et al. on X:

“Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Venetoclax plus decitabine NOT INFERIOR to intensive chemo in young fit AML.

VEN+DEC was well tolerated.”

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Authors: Jing Lu, et al.

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

 

AML cancer chemotherapy decitabine fight against cancer Global fight against cancer Jing Lu Mayo Clinic OncoDaily Oncology Talha Badar venetoclax
Special Coverage
Blog
May 22, 2025, 02:23
Toufic Kachaamy: Excited to announce a session on the ethical frontiers of AI in medicine on the Brains and Guts podcast
Career
May 22, 2025, 01:45
Jame Abraham: Congratulations to Agrima Mian for receiving the Research Training Award for Fellows
Blog
May 21, 2025, 21:13
2025 Chinese Congress on Holistic Integrative Oncology (CCHIO)
Insight
May 21, 2025, 19:15
Haydeé Verduzco-Aguirre shared study on 20-year breast cancer trends and treatment gaps in São Paulo
Insight
May 21, 2025, 19:10
Samuel Hume: Top 5 advances in medicine this week
Insight
May 21, 2025, 19:04
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology